Factors associated with myocarditis in patients with cancer treated with immune checkpoint inhibitors

被引：0
|
作者：
Izadi, Zara
Zhang, Yan
Lou, Youbei
Dreyfus, Brian
Plautz, Greg
Wolf, Robert
Cooper, Leslie
机构：
[1] Bristol Myers Squibb, Princeton, NJ USA
[2] Mayo Clin, Jacksonville, FL 32224 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e14674
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Prognostic impact and risk factors of cancer-associated thrombosis events in stage-IV cancer patients treated with immune checkpoint inhibitors
    Kewan, Tariq
    Ko, Taeyeong
    Flores, Monica
    Sallam, Yacoub
    Haddad, Abdo
    Daw, Hamed
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2021, 106 (05) : 682 - 688
  • [42] Immune-Related Adverse Events in Cancer Patients Treated With Immune Checkpoint Inhibitors
    Sandigursky, Sabina
    Mor, Adam
    CURRENT RHEUMATOLOGY REPORTS, 2018, 20 (10)
  • [43] Factors affecting tumor responders and predictive biomarkers of toxicities in cancer patients treated with immune checkpoint inhibitors
    Yao, Liqin
    Jia, Gang
    Lu, Lingeng
    Bao, Ying
    Ma, Wenxue
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2020, 85
  • [44] Immune-Related Adverse Events in Cancer Patients Treated With Immune Checkpoint Inhibitors
    Sabina Sandigursky
    Adam Mor
    Current Rheumatology Reports, 2018, 20
  • [45] Mechanisms of Immune-Related Complications in Cancer Patients Treated with Immune Checkpoint Inhibitors
    Konig, David
    Laubli, Heinz
    PHARMACOLOGY, 2021, 106 (3-4) : 123 - 136
  • [46] INTERSTITIAL NEPHRITIS IN PATIENTS TREATED WITH IMMUNE CHECKPOINT INHIBITORS: RISK FACTORS AND TREATMENT
    Ghamrawi, Ranine
    Manohar, Sandhya
    Goksu, Busra N. Bacik
    Herrmann, Sandra
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2019, 73 (05) : 674 - 674
  • [47] Exploration of Factors Relating to Paradoxical Immune Response in Patients Treated with Immune Checkpoint Inhibitors for NSCLC
    Cardona, A. F.
    Arrieta, O. G.
    Ruiz-Patino, A.
    Zatarain Barron, Z. L.
    Rojas, L. L.
    Corrales, L.
    Martin, C.
    Barron, F.
    Sotelo, C.
    Rodriguez, J.
    Ricaurte, L.
    Freitas, H.
    Cordeiro De Lima, V.
    Mas, L.
    Avila, J.
    Bravo, M.
    Mayorga, D.
    Archila, P.
    Otero, J.
    Carranza, H.
    Vargas, C.
    Rosell, R.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S971 - S971
  • [48] Cardiotoxicity of Immune Checkpoint Inhibitors: Beyond Myocarditis
    Lipe, Demis N.
    Palaskas, Nicolas L.
    Chaftari, Patrick
    JOURNAL OF MEDICAL TOXICOLOGY, 2022, 18 (01) : 63 - 64
  • [49] Cardiotoxicity of Immune Checkpoint Inhibitors: Beyond Myocarditis
    Demis N. Lipe
    Nicolas L. Palaskas
    Patrick Chaftari
    Journal of Medical Toxicology, 2022, 18 : 63 - 64
  • [50] Interstitial Pneumonitis Associated with Immune Checkpoint Inhibitors Treatment in Cancer Patients
    Delaunay, Myriam
    Lusque, Amelie
    Meyer, Nicolas
    Michot, Jean-Marie
    Raimbourg, Judith
    Cadranel, Jacques
    Zalcman, Gerard
    Gounant, Valerie
    Moro-Sibilot, Denis
    Girard, Nicolas
    Thiberville, Luc
    Planchard, David
    Metivier, Anne Cecile
    Barlesi, Fabrice
    Dansin, Eric
    Perol, Maurice
    Pichon, Eric
    Gautschi, Oliver
    Martin, Fruh
    Collot, Samia
    Jaffro, Marion
    Prevot, Gregoire
    Milia-Baron, Julie
    Mazieres, Julien
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1292 - S1293
12345